VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $168,000 | -33.1% | 35,712 | +1.8% | 0.07% | -31.7% |
| Q4 2020 | $251,000 | -7.4% | 35,079 | +38.0% | 0.10% | -26.8% |
| Q3 2020 | $271,000 | -25.5% | 25,411 | -12.0% | 0.14% | -17.4% |
| Q2 2020 | $364,000 | +49.2% | 28,874 | +8.1% | 0.17% | +72.0% |
| Q1 2020 | $244,000 | -42.9% | 26,708 | -12.7% | 0.10% | +42.9% |
| Q4 2019 | $427,000 | +137.2% | 30,608 | +193.5% | 0.07% | +94.4% |
| Q3 2019 | $180,000 | -40.0% | 10,430 | -5.3% | 0.04% | -42.9% |
| Q2 2019 | $300,000 | -38.9% | 11,011 | -57.1% | 0.06% | -94.0% |
| Q1 2019 | $491,000 | +78.5% | 25,651 | -12.2% | 1.04% | +2123.4% |
| Q4 2018 | $275,000 | -33.6% | 29,207 | +33.6% | 0.05% | +9.3% |
| Q3 2018 | $414,000 | -43.5% | 21,869 | -41.7% | 0.04% | -93.4% |
| Q2 2018 | $733,000 | -27.0% | 37,502 | -29.8% | 0.65% | -25.6% |
| Q1 2018 | $1,004,000 | +156.1% | 53,407 | +126.4% | 0.87% | +77.0% |
| Q4 2017 | $392,000 | – | 23,586 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |